Capital Research Global Investors maintained its stake in shares of Proto Labs, Inc. (NYSE:PRLB) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 466,700 shares of the industrial products company’s stock at the end of the second quarter. Capital Research Global Investors owned approximately 1.75% of Proto Labs worth $31,386,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Victory Capital Management Inc. boosted its stake in shares of Proto Labs by 65.6% in the first quarter. Victory Capital Management Inc. now owns 1,974 shares of the industrial products company’s stock valued at $101,000 after purchasing an additional 782 shares during the period. Ameritas Investment Partners Inc. purchased a new position in shares of Proto Labs in the first quarter valued at approximately $109,000. UBS Group AG boosted its stake in shares of Proto Labs by 128.0% in the first quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock valued at $133,000 after purchasing an additional 11,895 shares during the period. SG Americas Securities LLC boosted its stake in shares of Proto Labs by 27.1% in the first quarter. SG Americas Securities LLC now owns 2,830 shares of the industrial products company’s stock valued at $145,000 after purchasing an additional 603 shares during the period. Finally, Invictus RG purchased a new position in shares of Proto Labs in the first quarter valued at approximately $179,000.

Proto Labs, Inc. (PRLB) opened at 80.10 on Friday. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of 46.57 and a beta of 0.99. Proto Labs, Inc. has a 1-year low of $43.10 and a 1-year high of $82.50. The stock has a 50 day moving average of $74.40 and a 200 day moving average of $65.86.

Proto Labs (NYSE:PRLB) last posted its earnings results on Thursday, July 27th. The industrial products company reported $0.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.06. The firm had revenue of $82.04 million during the quarter, compared to the consensus estimate of $80.49 million. Proto Labs had a net margin of 14.59% and a return on equity of 11.75%. The company’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.45 EPS. Equities analysts expect that Proto Labs, Inc. will post $2.06 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/proto-labs-inc-prlb-position-held-by-capital-research-global-investors/1617762.html.

Several research firms have recently commented on PRLB. BidaskClub lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Friday. Piper Jaffray Companies reissued a “hold” rating and issued a $67.00 price objective on shares of Proto Labs in a research note on Friday, July 28th. Finally, Dougherty & Co raised shares of Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $56.00.

In related news, VP Robert Bodor sold 741 shares of the stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $73.84, for a total transaction of $54,715.44. Following the completion of the sale, the vice president now owns 17,319 shares of the company’s stock, valued at approximately $1,278,834.96. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 7.78% of the stock is currently owned by corporate insiders.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.